Rayner announced that it will mark an important milestone next month: the 10-year anniversary of FDA approval of C-flex 570C monofocal IOL for commercial use in the United States of America.
C-flex, the first IOL from a non-American manufacturer in over 2 decades to gain FDA approval, is a key product in Rayner’s portfolio and is one of the company’s most implanted lenses globally. It is based on the platform used across all of Rayner’s current and pipeline capsular bag IOLs.
James A Davison, MD, at the Wolfe Clinic, Marshalltown, Iowa, implanted the first US patient with a C-flex IOL on October 24, 2003 as part of the international, multisite clinical study.
“It was a great privilege to be part of the study for the Rayner foldable acrylic IOL and I join in celebrating its 10 year anniversary," Dr. Davidson said. "This lens has a unique and extremely stable three dimensional haptic structure and beautifully clear optic. It is easy to implant and centers very predictably. I really enjoy seeing it in my patients today.”